MeSH Browser

MeSH Supplementary: VAMA protocol
Unique ID: C075513
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C075513
Registry Number: 0
Heading Mapped to: *Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Methotrexate; Teniposide
Frequency: 3
Note: chemotherapy protocol of above four compounds for treating aggressive malignant lymphomas; also used in Tours-Poitiers-Limoges (TPL or TPL-84) protocol, a three-stage protocol where VAMA is used in stage two for consolidation therapy
Source: Haematologica 1991 Nov-Dec;76(6):479-84
Date of Entry: 1992/08/05
Revision Date: 2000/11/30

VAMA protocol MeSH Supplementary Concept Data 2024